Therapy of chronic idiopathic thrombocytopenic purpura in adults [see comments]

Open Access
Publisher Website
Google Scholar
Abstract
Chronic ITP is a common hematologic illness. Approximately three fourths of the patients respond to corticosteroids or splenectomy and need no further treatment. Patients refractory to these two therapeutic approaches are relatively resistant to present forms of treatment and are at much greater risk for morbidity and mortality. Future clinical studies evaluating therapy in this refractory group would be best performed in a cooperative group setting in which large numbers of patients could be treated in a prospective randomized manner.

This publication has 0 references indexed in Scilit: